Revance Therapeutics' Series E Round

Revance Therapeutics raised a round of funding on June 13, 2011.

Revance Therapeutics is a privately held specialty biopharmaceutical company which develops next generation products in dermatology and therapeutic medicine. Revance has developed a platform technolog…

Articles about Revance Therapeutics' Series E Round: